Additional Therapy with a Mistletoe Product during Adjuvant Chemotherapy of Breast Cancer Patients Improves Quality of Life: An Open Randomized Clinical Pilot Trial
Table 3
List of patients experiencing a neutropenia.
Group
ID
Visit number
Date (Visit)
Age
Stage
T
N
M
G
Leuco-cytes/nL
Neutro-phils/nL
HxA
18
2
26.04.2006
43
2
2
1
0
2
10.2
0.6
61
2
18.09.2006
50
2
2
0
0
2
2.6
0.9
42
7
03.11.2006
47
2
2
1
0
2
1.4
0.5
53
7
06.12.2006
44
2
2
1
0
2
1.6
0.4
57
7
22.12.2006
64
2
2
1
0
3
1.5
0.3
58
7
22.12.2006
37
2
2
0
0
3
2.5
0.7
75
7
07.03.2007
55
2
2
0
0
2
3.2
0.9
Control
13
3
26.04.2006
32
2
2
1
0
2
2.8
0.9
33
5
29.08.2006
60
2
2
0
0
2
2.4
0.9
87
6
26.03.2007
45
2
2
1
0
2
3.3
0.3
90
6
29.03.2007
52
2
1
0
0
3
2.6
0.8
51
7
08.12.2006
66
2
2
1
0
2
1.3
0.3
56
7
21.12.2006
53
2
2
1
0
2
3.5
0.9
62
7
31.01.2007
62
2
1
1
0
2
2.5
0.8
66
7
23.01.2007
44
1
1
0
0
2
2.4
0.8
90
7
19.04.2007
52
2
1
0
0
3
2.7
0.9
Seven patients of the HxA group and eight patients of the control group experienced a neutropenia (; 2-sided Chi square test) at day 21 of the respective cycle/visit.
